These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 20414426
1. Endoscopic Subureteral Injection for the Treatment of Vesicoureteral Reflux in Children: Polydimethylsiloxane (Macroplastique(R)) versus Dextranomer/Hyaluronic Acid Copolymer (Deflux(R)). Bae YD, Park MG, Oh MM, Moon du G. Korean J Urol; 2010 Feb; 51(2):128-31. PubMed ID: 20414426 [Abstract] [Full Text] [Related]
2. Prospective comparison and 1-year follow-up of a single endoscopic subureteral polydimethylsiloxane versus dextranomer/hyaluronic acid copolymer injection for treatment of vesicoureteral reflux in children. Oswald J, Riccabona M, Lusuardi L, Bartsch G, Radmayr C. Urology; 2002 Nov; 60(5):894-7; discussion 898. PubMed ID: 12429323 [Abstract] [Full Text] [Related]
3. Clinical efficacy and safety in children with vesicoureteral reflux of a single injection of two different bulking agents--polydimethylsiloxane (Macroplastique) or dextranomer/hyaluronic acid copolymer (Deflux): a short-term prospective comparative study. Kim SO, Shin BS, Hwang IS, Hwang EC, Oh KJ, Jung SI, Kang TW, Kwon D, Park K, Ryu SB. Urol Int; 2011 Nov; 87(3):299-303. PubMed ID: 21934268 [Abstract] [Full Text] [Related]
4. Efficacy of Bladder Ultrasound in Prediction of Resolution of Vesicoureteral Reflux After Endoscopic Subureteral Hyaluronic Acid/Dextranomer (Deflux) Injection. Aboutaleb H, Eldib DB, Farahat Y, Abouelgreed TA, Zanaty F. Urology; 2022 Jul; 165():299-304. PubMed ID: 35065987 [Abstract] [Full Text] [Related]
5. Proprietary non-animal stabilized hyaluronic acid/dextranomer gel (NASHA/Dx) for endoscopic treatment of grade IV vesicoureteral reflux: Long-term observational study. Stenbäck A, Olafsdottir T, Sköldenberg E, Barker G, Stenberg A, Läckgren G. J Pediatr Urol; 2020 Jun; 16(3):328.e1-328.e9. PubMed ID: 32414615 [Abstract] [Full Text] [Related]
6. Factors affecting the success of endoscopic treatment of vesicoureteral reflux and comparison of two dextranomer based bulking agents: does bulking substance matter? Dogan HS, Altan M, Citamak B, Bozaci AC, Koni A, Tekgul S. J Pediatr Urol; 2015 Apr; 11(2):90.e1-5. PubMed ID: 25791422 [Abstract] [Full Text] [Related]
12. [Long-term results after endoscopic subureteral injection for VUR using dextranomer/hyaluronic acid copolymer : a five years experience]. Seibold J, Werther M, Sievert KD, Stenzl A. Urologe A; 2010 Apr; 49(4):536-9. PubMed ID: 20063087 [Abstract] [Full Text] [Related]
14. What are the predictive factors leading to ureteral obstruction following endoscopic correction of VUR in the pediatric population? Chertin B, Mele E, Kocherov S, Zilber S, Gerocarni Nappo S, Capozza N. J Pediatr Urol; 2018 Dec; 14(6):538.e1-538.e7. PubMed ID: 29885870 [Abstract] [Full Text] [Related]
15. Subureteral injection of Deflux for correction of reflux: analysis of factors predicting success. Lavelle MT, Conlin MJ, Skoog SJ. Urology; 2005 Mar; 65(3):564-7. PubMed ID: 15780377 [Abstract] [Full Text] [Related]
16. Endoscopic Injection of Dextranomer/Hyaluronic Acid as First Line Treatment in 851 Consecutive Children with High Grade Vesicoureteral Reflux: Efficacy and Long-Term Results. Friedmacher F, Colhoun E, Puri P. J Urol; 2018 Sep; 200(3):650-655. PubMed ID: 29551405 [Abstract] [Full Text] [Related]
17. Comparison of results of endoscopic correction of vesicoureteral reflux in children using two bulking substances: Dextranomer/hyaluronic acid copolymer (Deflux) versus polyacrylate-polyalcohol copolymer (Vantris). Warchol S, Krzemien G, Szmigielska A, Bombinski P, Brzewski M, Dudek-Warchol T. J Pediatr Urol; 2016 Aug; 12(4):256.e1-4. PubMed ID: 27593921 [Abstract] [Full Text] [Related]